Nordic Issuing

Ongoing case

Cessatech A/S

Back to all cases

Cessatech A/S

12 Jan - 26 Jan 2024Warrant exercise TO2

The Danish pharmaceutical company Cessatech A/S specializes in research and development of an analgesic nasal spray for children. Cessatech’s spray is intended to be used in hospitals for acute pain and in connection with medical procedures.

Read more at the company's website

The offer in summary

Subscription period: 12 january - 26 january 2024

Price per share: DKK 4.71

Trading with warrants: Until 24 January 2024

The offer: 3,838,110 new shares

Marketplace: Spotlight Stock Market

Terms: One (1) warrant of series TO 2 gives the holder the right to subscribe for one (1) new share.

Financial advisor: Translution Capital


  Tegningsformular TO 2


Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.